Dr. Rosenthal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Medical Center East, South Tower 37232
1215 21st Ave South
Nashville, TN 37232Phone+1 650-723-4000- Is this information wrong?
Summary
- Eben L. Rosenthal is a surgeon-scientist who serves as the Guy Maness Professor and Chair of Otolaryngology. His primary interests are free flap surgery and molecular imaging. He continues to be clinically active as an oncologic and microvascular reconstructive surgeon. He was previously the John and Ann Doerr Medical Director of the Stanford Cancer Center from 2015-2021.
Dr. Rosenthal has been continually funded by the NIH for the past 15 years to conduct bench to bedside translational studies in targeted therapy and molecular imaging. He has conducted over a dozen early phase clinical trials for diagnostic and therapeutic agents for the treatment of solid tumors. He is part of a multidisciplinary team of clinicians and basic scientists that perform preclinical animal studies including nonhuman primate IND-enabling studies, and first-in-human clinical trials. The team assesses near infrared fluorescent contrast agents for use in the operating room to make the cancer visible. Ongoing clinical trials include brain, lung, pancreas, skin and head and neck tumors. The lab also focuses on molecular imaging of fluorescently labeled therapeutic antibodies to measure cellular delivery of therapies to tumors and adjacent tissues.
Dr. Rosenthal grew up in Ann Arbor, Michigan and went to Medical School and Residency at the University of Michigan after attending Haverford College for his undergraduate education
Education & Training
- University of Michigan Health SystemResidency, Otolaryngology - Head and Neck Surgery, 1995 - 2000
- University of Michigan Health SystemInternship, Transitional Year, 1994 - 1995
- University of Michigan Medical SchoolClass of 1994
Certifications & Licensure
- OR State Medical License 2000 - Present
- TN State Medical License 2021 - 2026
- CA State Medical License 2015 - 2025
- AL State Medical License Active through 2015
- MI State Medical License 1997 - 2002
- American Board of Otolaryngology - Head and Neck Surgery Otolaryngology
Awards, Honors, & Recognition
- Fellow (FAAO-HNS) American Academy of Otolaryngology - Head and Neck Surgery
- Fellow (FACS) American College of Surgeons
- America's Top Doctors Castle Connolly, 2012-2014
- Join now to see all
Clinical Trials
- A Trial of Erlotinib + Radiotherapy for Cutaneous Squamous Cell Carcinoma Start of enrollment: 2006 Aug 01
- UAB 0718 - Phase II Trial to Assess Target Oral Therapy as Adjuvant Chemoprevention in High-Risk Head and Neck Cancer Start of enrollment: 2007 Dec 01
- Cetuximab IRDye800 Study as an Optical Imaging Agent to Detect Cancer During Surgical Procedures Start of enrollment: 2015 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- Efficacy of Depatuxizumab Mafodotin (ABT-414) in preclinical models of head and neck cancer.Mani, L., Naveed, A., McAdoo, A., Hom, M., Rosenthal, E.> ;Carcinogenesis. 2024 Feb 20
- Frontal and anterior temporal hypometabolism post chemoradiation in head and neck cancer: A real-world PET study.Bishay, S., Robb, W., Schwartz, T., Smith, D., Lee, L., Lynn, C., Clark, T., Jefferson, A., Warner, J., Murphy, B., Hohman, T., Koran, M., Rosenthal, E.> ;Journal of Neuroimaging. 2023 Dec 26
- Identification of Optimal Tissue-Marking Dye Color for Pathological Evaluation in Fluorescence Imaging Using IRDye800CW.Kondo, T., Nishio, N., Park, J., Mani, L., Naveed, A., Tanaka, H., Lewis, J., Rosenthal, E., Hom, M.> ;Molecular Imaging and Biology. 2024 Feb 1
- Join now to see all
Journal Articles
- Correction to: ASO Author Reflections: Fluorescent-Guided Surgery to Augment Pancreatic Cancer SurgeryEben Rosenthal, MD, Annals of Surgical Oncology
Press Mentions
- Cutting-Edge Advances in Cancer Treatment Are Underway. Here Are 3 That Could Change LivesApril 20th, 2023
- Study Tracks Smell, Taste Loss Associated with COVIDSeptember 23rd, 2021
- Stanford’s Eben Rosenthal Named to Lead VUMC’s Otolaryngology-Head and Neck SurgeryJune 11th, 2021
Grant Support
- 8th Annual Conference On Head And Neck CancerNational Institute Of Dental &Craniofacial Research2012
- CD147 As A Novel Target In Head And Neck CancerNational Cancer Institute2010–2012
- Fluorescently Labeled Anti-Egfr To Guide Removal Of Lymph Node MetastasisNational Institute Of Dental &Craniofacial Research2009–2010
- Tumor Stromal Interactions In Head And Neck CancerNational Cancer Institute2005–2009
- Role Of Fibroblast-Derived MT1-MMP In Oral CancerNational Institute Of Dental &Craniofacial Research2005–2006
Professional Memberships
- Fellow
- Member
- Collegium Oto-Rhino-Laryngologicum Amicitiae SacrumMember
Hospital Affiliations
- Vanderbilt University Medical CenterNashville, Tennessee
- Stanford Health CarePalo Alto, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: